Medi-Caps Limited (BOM:523144)
India · Delayed Price · Currency is INR 23.25
-1.31 (-5.33%)
At close: Feb 12, 2026
Medi-Caps Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 160.12 | 254.77 | 273.45 | 493.71 | 698.71 | 587.19 |
Other Revenue | -0.49 | - | - | - | - | - |
| 159.63 | 254.77 | 273.45 | 493.71 | 698.71 | 587.19 | |
Revenue Growth (YoY) | -39.50% | -6.83% | -44.61% | -29.34% | 18.99% | 31.65% |
Cost of Revenue | 70.42 | 106.52 | 95.18 | 229.05 | 301.11 | 293.63 |
Gross Profit | 89.21 | 148.26 | 178.28 | 264.66 | 397.61 | 293.56 |
Selling, General & Admin | 80.56 | 81.71 | 78.41 | 84.93 | 92.22 | 74.77 |
Other Operating Expenses | 84.38 | 84.82 | 100.21 | 129.11 | 205.22 | 97.02 |
Operating Expenses | 182.46 | 183.71 | 195.49 | 231.47 | 315.57 | 187 |
Operating Income | -93.25 | -35.46 | -17.21 | 33.19 | 82.04 | 106.56 |
Interest Expense | -0.38 | -0.25 | - | -0.02 | -0.1 | - |
Interest & Investment Income | 6.61 | 6.61 | 0.04 | 0.03 | 5.3 | - |
Currency Exchange Gain (Loss) | 1.69 | 1.69 | 2.79 | 8.88 | 8.59 | 5.84 |
Other Non Operating Income (Expenses) | 21.51 | 1.2 | -0 | - | 0 | - |
EBT Excluding Unusual Items | -63.82 | -26.21 | -14.38 | 42.08 | 95.83 | 112.4 |
Gain (Loss) on Sale of Investments | 17.8 | 17.8 | 1.92 | 7.13 | 4.27 | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.47 | - |
Pretax Income | -46.03 | -8.41 | -12.46 | 49.21 | 100.58 | 112.4 |
Income Tax Expense | -2.42 | -2.7 | 9.95 | 30.54 | 0.14 | -0.05 |
Earnings From Continuing Operations | -43.61 | -5.71 | -22.41 | 18.66 | 100.43 | 112.45 |
Earnings From Discontinued Operations | - | - | - | -1.11 | 0.37 | -1.16 |
Net Income | -43.61 | -5.71 | -22.41 | 17.56 | 100.81 | 111.29 |
Net Income to Common | -43.61 | -5.71 | -22.41 | 17.56 | 100.81 | 111.29 |
Net Income Growth | - | - | - | -82.58% | -9.42% | - |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Change (YoY) | 0.47% | - | - | - | - | - |
EPS (Basic) | -3.49 | -0.46 | -1.80 | 1.41 | 8.08 | 8.92 |
EPS (Diluted) | -3.50 | -0.46 | -1.80 | 1.41 | 8.08 | 8.92 |
EPS Growth | - | - | - | -82.58% | -9.47% | - |
Free Cash Flow | - | 47.43 | 65.93 | -72.44 | 42.28 | 130.62 |
Free Cash Flow Per Share | - | 3.80 | 5.29 | -5.81 | 3.39 | 10.47 |
Gross Margin | 55.89% | 58.19% | 65.20% | 53.61% | 56.91% | 49.99% |
Operating Margin | -58.42% | -13.92% | -6.29% | 6.72% | 11.74% | 18.15% |
Profit Margin | -27.32% | -2.24% | -8.20% | 3.56% | 14.43% | 18.95% |
Free Cash Flow Margin | - | 18.62% | 24.11% | -14.67% | 6.05% | 22.25% |
EBITDA | -75.83 | -18.28 | -0.35 | 51.3 | 101.07 | 125.08 |
EBITDA Margin | -47.51% | -7.17% | -0.13% | 10.39% | 14.46% | 21.30% |
D&A For EBITDA | 17.42 | 17.18 | 16.87 | 18.11 | 19.03 | 18.52 |
EBIT | -93.25 | -35.46 | -17.21 | 33.19 | 82.04 | 106.56 |
EBIT Margin | -58.42% | -13.92% | -6.29% | 6.72% | 11.74% | 18.15% |
Effective Tax Rate | - | - | - | 62.07% | 0.14% | - |
Revenue as Reported | 207.23 | 282.07 | 278.2 | 509.74 | 717.85 | 593.03 |
Advertising Expenses | - | 5.88 | 7.72 | 6.42 | 13.86 | 7.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.